Results 61 to 70 of about 868 (101)

[Pharmaceutical marketing and intoxications due to emulation]. [PDF]

Aten Primaria, 2003
Burrillo-Putze G, Miró O, Nogué Xarau S.   +2 more
europepmc   +1 more source

[Randomised clinical trial to evaluate the efficacy of a multi-factorial intervention to reduce hospitalisation and improve the quality of life of patients with heart failure]. [PDF]

Aten Primaria, 2005
Brotons C, Martínez M, Rayó E, Morralla C, Ballarín E, Pérez E, Investigadores del Estudio IC-DOM.   +6 more
europepmc   +1 more source

[Restless legs syndrome: concerning two cases]. [PDF]

Aten Primaria, 2002
Caudevilla Gálligo F, Figueroa Martín-Buitrago M, Sánchez González R.   +2 more
europepmc   +1 more source

[Risk factors of a new cardio-embolic cerebral accident in non-valvular atrial fibrillation treated with acenocoumarol]. [PDF]

Aten Primaria, 2001
Vázquez Muñoz E, Gómez Cerezo J, Fernández Pavón A.   +2 more
europepmc   +1 more source

[Decrease in mortality on spironolactone being added to the conventional treatment of heart failure]. [PDF]

Aten Primaria, 2000
Soto Alvarez J.
europepmc   +1 more source

[Serious haemorrhages linked to acenocoumarol in a rural area]. [PDF]

Aten Primaria, 2005
Calvo Romero JM, Lima Rodríguez EM.
europepmc   +1 more source

[Prevention of thromboembolic disease in patients with heart disease]. [PDF]

Aten Primaria, 2000
Galindo G, Peiró R, Plana A, Navarro MA, Berdié J, Morató J.   +5 more
europepmc   +1 more source

[Diagnosis and management of type 2 diabetes]. [PDF]

Aten Primaria, 2010
Díez Espino J.
europepmc   +1 more source